Bioretec Ltd. has refined and expanded its esteemed Scientific Advisory Board (SAB). To further strengthen its strategic focus areas, Bioretec has assembled a distinguished group of key opinion leaders to represent expertise from the refocused RemeOs? portfolio.

These top-tier experts and surgeons, renowned for their significant contributions to orthopedics and medical research, will form Bioretec's Scientific Advisory Board. These eminent surgeons, specializing in orthopedic trauma (Prof. Dr. Klaus Dresing[i], Germany and Prof. Dr. Fan Liu[ii], China), foot and ankle surgery (Prof. Dr. Stefan Rammelt[iii], Germany and Dr. Robert Leland[iv], USA), pediatric orthopedic trauma (Prof. Dr. Theddy Slongo[v], Switzerland and Dr. Verena Schreiber[vi], USA) and spine surgery (Prof. Dr. Jeffrey Wang[vii], USA and Dr. Richard Assaker[viii], France), have been carefully selected to form Bioretec's high-powered SAB. More than just a group of big names, the SAB will play an integral role in guiding the company's processes regarding clinical product development, education and training programs, and engaging surgeon communities.

Bioretec is poised to transform orthopedic surgical practice with its new cutting-edge technology. The RemeOs? product line represents a major milestone, offering a breakthrough solution that combines the benefits of biodegradability, implant strength, and performance.

This transforming technology not only ensures effective treatment but also eliminates the need for subsequent implant removal surgeries, thereby enhancing patient comfort and reducing healthcare costs. The Scientific Advisory Board will work closely with Bioretec's executive team, contributing their valuable perspectives and knowledge to advance the company's research, development, and clinical strategies. Their collective insights, combined with their influence within the medical community, will empower Bioretec to push the boundaries of orthopedic innovation, ultimately benefiting patients worldwide.